Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusion

Molecular Membrane Biology

Volumn 25, Issue 1, 2008, Pages 83-94

  Rawat, Satinder S ^a,c   Zimmerman, Christina ^a,d   Johnson, Benitra T ^a,e   Cho, Edward ^b,f   Lockett, Stephen J ^b   Blumenthal, Robert ^a   Puri, Anu ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d HOOD COLLEGE   (United States)

^e CHILDREN S RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

CD4 receptor localization in the plasma membrane; Receptor mobility restriction and HIV 1 fusion

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; BIOENGINEERING; CELL FUSION; CELL MEMBRANE; CELL STRAIN 3T3; COMPARATIVE STUDY; CONTROLLED STUDY; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VIRUS ENVELOPE; VIRUS INFECTION;

ANIMALS; ANTIGENS, CD4; GENE PRODUCTS, ENV; HELA CELLS; HIV-1; HUMANS; MEMBRANE FLUIDITY; MICE; MUTATION; NIH 3T3 CELLS; RECEPTORS, CCR5; RECEPTORS, CXCR4; VIRUS INTERNALIZATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 37549047226     PISSN: 09687688     EISSN: 14645203     Source Type: Journal    
DOI: 10.1080/09687680701613713     Document Type: Article

References (38)

1. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. 1996. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958.
2. Bhattacharya J, Peters PJ, Clapham PR. 2004. Human immunodeficiency virus type 1 envelope glycoproteins that lack cytoplasmic domain cysteines: impact on association with membrane lipid rafts and incorporation onto budding virus particles. J Virol 78:5500-5506.
3. Broder CC, Dimitrov DS. 1996. HIV and the 7-transmembrane domain receptors. Pathobiology 64:171-179.
4. Campbell SM, Crowe SM, Mak J. 2001. Lipid rafts and HIV-1: from viral entry to assembly of progeny virions. J Clin Virol 22:217-227.
5. Deen KC, McDougal JS, Inacker R, Folena-Wasserman G, Arthos J, Rosenberg J, Maddon PJ, Axel R, Sweet RW. 1988. A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature 331:82-84.
6. Earl PL, Doms RW, Moss B. 1990. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proc Natl Acad Sci USA 87:648-652.
7. Earl PL, Koenig S, Moss B. 1991. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. J Virol 65:31-41.
8. Feng Y, Broder CC, Kennedy PE, Berger EA. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272:872-877.
9. Finnegan CM, Rawat SS, Cho EH, Guiffre DL, Lockett S, Merrill AH, Jr, Blumenthal R. 2007. Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion. J Virol 81:5294-5304.
10. Finnegan CM, Rawat SS, Puri A, Wang JM, Ruscetti FW, Blumenthal R. 2004. Ceramide, a target for antiretroviral therapy. Proc Natl Acad Sci USA 101:15452-15457.
11. Gallo SA, Finnegan CM, Viard M, Raviv Y, Dimitrov A, Rawat SS, Puri A, Durell S, Blumenthal R. 2003. The HIV Env-mediated fusion reaction. Biochim Biophys Acta 1614:36-50.
12. Hammache D, Yahi N, Maresca M, Pieroni G, Fantini J. 1999. Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3). J Virol 73:5244-5248.
13. Horejsi V. 2003. The roles of membrane microdomains (rafts) in T cell activation. Immunol Rev 191:148-164.
14. Hug P, Lin HM, Korte T, Xiao X, Dimitrov DS, Wang JM, Puri A, Blumenthal R. 2000. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/ or CCR5. J Virol 74:6377-6385.
15. Kotani M, Ozawa H, Kawashima I, Ando S, Tai T. 1992. Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides. Biochim Biophys Acta 1117:97-103.
16. Kozak SL, Heard JM, Kabat D. 2002. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus. J Virol 76:1802-1815.
17. Liao Z, Cimakasky LM, Hampton R, Nguyen DH, Hildreth JE. 2001. Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res Hum Retroviruses 17:1009-1019.
18. Lippincott-Schwartz J, Presley JF, Zaal KJ, Hirschberg K, Miller CD, Ellenberg J. 1999. Monitoring the dynamics and mobility of membrane proteins tagged with green fluorescent protein. Methods Cell Biol 58:261-281.
19. Markovic I, Clouse KA. 2004. Recent advances in understanding the molecular mechanisms of HIV-1 entry and fusion: revisiting current targets and considering new options for therapeutic intervention. Curr HIV Res 2:223-234.
20. Nayak DP, Hui EK. 2004. The role of lipid microdomains in virus biology. Subcell Biochem 37:443-491.
21. Nguyen DH, Giri B, Collins G, Taub DD. 2005. Dynamic reorganization of chemokine receptors, cholesterol, lipid rafts, and adhesion molecules to sites of CD4 engagement. Exp Cell Res 304:559-569.
22. Pal R, Nair BC, Hoke GM, Sarngadharan MG, Edidin M. 1991. Lateral diffusion of CD4 on the surface of a human neoplastic T-cell line probed with a fluorescent derivative of the envelope glycoprotein (gp120) of human immunodeficiency virus type 1 (HIV-1). J Cell Physiol 147:326-332.
23. Percherancier Y, Lagane B, Planchenault T, Staropoli I, Altmeyer R, Virelizier JL, Arenzana-Seisdedos F, Hoessli DC, Bachelerie F. 2003. HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains. J Biol Chem 278:3153-3161.
24. Pohlmann S, Reeves JD. 2006. Cellular entry of HIV: evaluation of therapeutic targets. Curr Pharm Des 12:1963-1973.
25. Popik W, Alce TM. 2004. CD4 receptor localized to nonraft membrane microdomains supports HIV-1 entry. Identification of a novel raft localization marker in CD4. J Biol Chem 279:704-712.
26. Popik W, Alce TM, Au WC. 2002. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. J Virol 76:4709-4722.
27. Pucadyil TJ, Chattopadhyay A. 2006. Effect of cholesterol on lateral diffusion of fluorescent lipid probes in native hippocampal membranes. Chem Phys Lipids 143:11-21.
28. Puri A, Paternostre M, Blumenthal R. 1906. Lipids in viral fusion. Methods Mol Biol 199:61-81.
29. Rawat SS, Eaton J, Gallo SA, Martin TD, Ablan S, Ratnayake S, Viard M, KewalRamani VN, Wang JM, Blumenthal R, Puri A. 2004. Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion. Virology 318:55-65.
30. Rawat SS, Gallo SA, Eaton J, Martin TD, Ablan S, KewalRamani VN, Wang JM, Blumenthal R, Puri A. 2004. Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion. J Virol 78:7360-7368.
31. Rawat SS, Johnson BT, Puri A. 2005. Sphingolipids: modulators of HIV-1 infection and pathogenesis. Biosci Rep 25:329-343.
32. Rawat SS, Viard M, Gallo SA, Blumenthal R, Puri A. 2006. Sphingolipids, cholesterol, and HIV-1: A paradigm in viral fusion. Glycoconj J 23:189-197.
33. Singer II, Scott S, Kawka DW, Chin J, Daugherty BL, DeMartino JA, DiSalvo J, Gould SL, Lineberger JE, Malkowitz L, Miller MD, Mitnaul L, Siciliano SJ, Staruch MJ, Williams HR, Zweerink HJ, Springer MS. 2001. CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells. J Virol 75:3779-3790.
34. Steffens CM, Hope TJ. 2003. Localization of CD4 and CCR5 in living cells. J Virol 77:4985-4991.
35. Steffens CM, Hope TJ. 2004. Mobility of the human immunodeficiency virus (HIV) receptor CD4 and coreceptor CCR5 in living cells: implications for HIV fusion and entry events. J Virol 78:9573-9578.
36. Viard M, Parolini I, Sargiacomo M, Fecchi K, Ramoni C, Ablan S, Ruscetti FW, Wang JM, Blumenthal R. 2002. Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells. J Virol 76:11584-11595.
37. Wyss S, Dimitrov AS, Baribaud F, Edwards TG, Blumenthal R, Hoxie JA. 2005. Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail. J Virol 79:12231-12241.
38. Yamamura S, Handa K, Hakomori S. 1997. A close association of GM3 with c-Src and Rho in GM3-enriched microdomains at the B16 melanoma cell surface membrane: a preliminary note. Biochem Biophys Res Commun 236:218-222.